INTRODUCTION
Mast cells have been shown to activate a sequence of cellular events that causes secretion in response to various stimulants [1] . Cross-linking of membranebound receptors for antibody ( or IgE) induces mobilization of Ca2", enhanced phospholipid metabolism and release of histamine, leukotrienes and prostaglandins, all of which play a role in acute allergic reactions. Leukotrienes and prostaglandins are derived from arachidonic acid released from phospholipids, and therefore its release plays a crucial role in the regulation of leukotriene and prostaglandin synthesis. Two main pathways for arachidonic acid release in activated cells have been proposed: phospholipase C/diacylglycerol lipase [2] and phospholipase A2 [3] .
Although there have been many studies of these pathways, namely in platelets [2, [4] [5] [6] , neutrophils [7] , macrophages [8, 9] , pancreatic. acinar cells [10] , RBL-2H3 cells [11] , and NIH-3T3 cells [12] , a consensus has not yet emerged regarding the relative contribution of the two pathways of arachidonate mobilization. We have previously suggested that the phospholipase A2 pathway may play a major role in arachidonic acid liberation in mast cells stimulated with compound 48/80 or the ionophore A23187 [13, 14] . However, no studies to date have investigated arachidonic acid mobilization in antigen-stimulated mast cells.
Although it is conceivable that arachidonate-release pathways may differ with the type of cell or stimuli, there are several other explanations for the controversy about the primary source of the released arachidonate, one of which may be the lack of specific inhibitors for either phospholipase C or phospholipase A2. In addition, the [3Hlarachidonate labelling conditions have to be taken into consideration. Colard et al. [15] To obtain the anti-[DNP-Ascaris suum (DNP-As)] serum, rats were immunized by the method of Tada & Okamura [18] . Briefly, rats were injected with 0.5 ml of a mixture of 1 mg of DNP-As protein with 1010 killed Bordetella pertussis cells in the four footpads. Rats were boosted 5 days later with 0.5 mg of DNP-As protein injected into the back muscle. On the third day after the second injection, anti-DNP-As serum was separated from blood obtained from the abdominal aorta under pentobarbital anaesthesia. The antiserum was freezedried and stored at -20 'C. A passive cutaneous anaphylactic test performed at 48 h to detect IgE antibody showed a titre of 1:512.
Isolation of rat mast cells
Mast cells were obtained from the peritoneal cavity of Wistar rats and purified by a Percoll-gradient method [19] . Briefly, rats were exsanguinated by decapitation and then 20 ml of ice-cold THG medium [NaCl (137 mM)/ KCl (2.7 mM)/NaH2PO4 (0.4 mM)/CaCl2 (1.8 mM)/MgCl2 (1 mM)/glucose (5.6 mM)/Hepes (10 mM)/gelatin (1 mg/ ml)/heparin (5 units/ml), pH 7.4] was injected into the peritoneal cavity. The trunk of the rat was massaged more than 100 times, and the medium was recovered by aspiration and centrifuged (150 g, 5 min, 4°C). The pellet was resuspended in 1.6 ml of THG medium. The cell suspension was mixed with 3.6 ml of Percoll and 0.4 ml of 10-fold-concentrated phosphate-free THG, overlaid with 1 ml of THG, and then centrifuged (200 g, 15 min, 4°C). Mast cells were obtained from the pellet, washed twice, and resuspended in THG medium. Mastcell preparations were about 95 % pure as assessed by Toluidine Blue staining, and more than 95 % of cells were viable as judged by Trypan Blue uptake.
Lipid metabolism
Purified [4] as scintillant.
Histamine assay At the end of the labelling period, a portion of the mast-cell suspension was assayed for measurement of spontaneous histamine release. The remaining portion was washed twice and suspended to a density of 2 x 105 cells/0.48 ml in the THG medium in the presence of PS (10 jug/ml). The cells were then stimulated with DNP-As (1 ug/ml) for the indicated periods and the reaction was terminated by adding 1 ml of ice-cold 10 mM-EGTAcontaining THG medium. Histamine in the supernatant and the pellet was determined by the method of Shore et al. [21] , and percentage release was expressed as the ratio of histamine in the supernatant to the sum of that in the supernatant and pellet.
Materials [5,6,8,9,11,12,14,15- (Fig. 1) . The radioactivity of [3H]arachidonate in the total lipid progressively increased in cells incubated at 37°C, whereas with cells incubated at 30°C a plateau was reached at 4 h. In the 37°C-incubated cells, except for phosphatidic acid (PA), the 3H radioactivity in other phospholipid fractions gradually increased up to 6 h of incubation. The radioactivity in the non-esterified-fattyacid (NEFA) fraction was markedly decreased as phospholipids acquired radioactivity.
By contrast, in 30°C-incubated cells, 3H radioactivity incorporation into various phospholipids reached a plateau by 4 h after a gradual increase. In addition, the level of radiolabelled NEFA remained stable during the incubation at 30 'C. These results indicated that the 4 h incubation at 30 'C was the more appropriate for equilibrium labelling in further studies.
We then investigated histamine release from cells labelled for various periods of time. In the 30°C-incubated cells the spontaneous release was less than 10% up to 4 h and, when cells were labelled for 8 h at 30 'C, stimulation with antigen DNP-As resulted in more than 60% histamine release, indicating a good responsiveness to antigenic stimulation. By contrast, in 37 'C-incubated cells, the spontaneous release increased with time, reaching as high as 70 % at 8 h, the stimulationinduced histamine release being decreased in a reciprocal manner. The time course of histamine release in response to DNP-As was examined in cells that had been incubated for 4 h at 30 'C. Histamine release was observed to be about half-maximal at 5 s and reached a maximum On the basis of these results [labelling pattern (Fig. 1 ), histamine-release activity and cell viability], we chose the [3H]arachidonate labelling conditions of 4 h at 30 'C to examine arachidonate mobilization.
Arachidonic acid liberation in mast cells stimulated with DNP-As at 1 sg/ml was investigated in the presence of PS (10 4g/ml). The 3H radioactivity in the NEFA fraction separated by neutral-lipid t.l.c. was low (Fig.  2a) . This implies that the released arachidonic acid could have been immediately metabolized via lipoxygenase or cyclo-oxygenase. This was confirmed by the experiment using BW755C, an inhibitor of both lipoxygenase and cyclo-oxygenase [22] . The 3H radioactivity in NEFA exhibited a transient increase in the mast cells pretreated with 100 /tM-BW755C (Fig. 2b) . Since the neutral-lipid fraction separated by two-dimensional t.l.c. contained arachidonic acid and its metabolites, the changes in 3H radioactivity of this fraction reflected the overall level of released arachidonate. Fig. 3 illustrates the changes in [3H]arachidonate distribution in various lipids on stimulation with DNP- increase on stimulation, which may reflect some transacylation, a phenomenon that has been observed in other cells [15, 23] . It is therefore conceivable that, in antigenstimulated mast cells, arachidonic acid is liberated through two routes, namely the phospholipase A2 and the phospholipase C/diacylglycerol lipase pathways, and that the former may make a major contribution to the phospholipid changes occurring on stimulation. We previously suggested that arachidonic acid release could be mediated by phospholipase A2 and that the major source was PC in mast cells stimulated with concanavalin A [14] .
To assess the role played by phospholipase A2, a commonly used inhibitor of the enzyme, namely mepacrine [24] , was used in the present study. Mast cells were incubated with 0.2 mM-mepacrine for 5 min, and then stimulated with DNP-As (1 ,ug/ml) for 1 min (Fig. 4) . Mepacrine pretreatment barely affected antigen-induced PI hydrolysis and the production of both DG and PA (which are the immediate metabolites in the phospholipase C pathway). However, antigen-induced PC hydrolysis was decreased in mepacrine-pretreated cells, and the antigen-induced [3H]arachidonate release was decreased to 35 %. These results suggest that PC serves as a substrate for phospholipase A2, and that the arachidonate released by antigen induction is mainly derived from PC via phospholipase A2. On the other hand, an appreciable decreases of 3H radioactivity in PC in the presence of mepacrine could indicate two possibilities. One is that the concentration (0.2 mM) of the drug exerts incomplete inhibition of phospholipase A2; since higher concentrations of mepacrine have been found to inhibit phospholipase C [25] , we have used only 0.2 mM-mepacrine in the present study. An alternative possibility is the novel activity of a PC-specific phospholipase C producing DG, as has been observed in other cells [26, 27] . We have not yet identified this pathway in antigen-stimulated cells.
In summary, mast cells equilibrium-labelled with [3H]arachidonate for 4 h at 30°C preserve good responsiveness to the antigen. On receptor-induced stimulation by antigen, arachidonic acid is released mainly by phospholipase A2 action upon PC, and the remainder originates from PI by a sequential action of phospholipase C and DG lipase.
